Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.

Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.

BACKGROUND: The antithrombotic efficacy of aspirin is attributed to its inhibition of the enzyme prostaglandin G/H synthase, which is necessary for the formation of thromboxane A2 in platelets. Thromboxane A2 is a potent vasoconstrictor and platelet agonist. However, the formation of prostacyclin by...

Descripció completa

Dades bibliogràfiques
Autors principals:	Clarke, R, Mayo, G, Price, P, FitzGerald, G
Format:	Journal article
Idioma:	English
Publicat:	1991

Ítems similars

Expression changes of prostacyclin and thromboxane in blood of rats with tail vibration
per: Ziyu CHEN, et al.
Publicat: (2022-11-01)

The state of the prostacyclin-thromboxane system in patients after aorto-coronary bypass surgery
per: Kattakhanova R. Yu., et al.
Publicat: (2023-01-01)

Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy.
per: Opeyemi Abayomi Obilade, et al.
Publicat: (2017-01-01)

Thromboxane-prostacyclin balance and platelet aggregability in patients with minor cardiac abnormalities
per: Aleksandr Valentinovich Yagoda, et al.
Publicat: (2010-09-01)

Combined administration of aspirin and a specific thrombin inhibitor in man.
per: Clarke, R, et al.
Publicat: (1991)

Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT.
per: Thomas J Montine, et al.
Publicat: (2010-02-01)

Effects of Aspirin and Prednisone on Platelet Function and Thromboxane Synthesis in Healthy Dogs
per: John M. Thomason, et al.
Publicat: (2019-11-01)

Aspirin affects early phases of metastasis through the inhibition of COX-1-thromboxane A2 axis
per: Lucotti, S
Publicat: (2016)

Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2
per: Lucotti, S, et al.
Publicat: (2019)

Restoration of prostacyclin synthase in vascular smooth muscle cells after aspirin treatment: regulation by epidermal growth factor.
per: J M Bailey, et al.
Publicat: (1985-01-01)

Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation
per: Giovanna Petrucci, et al.
Publicat: (2022-12-01)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
per: Parish, S, et al.
Publicat: (2023)

Prostacyclin Synthesis and Prostacyclin Receptor Expression in the Porcine Myometrium: Prostacyclin Potential to Regulate Fatty Acid Transporters, Cytokines and Contractility-Related Factors
per: Agnieszka Blitek, et al.
Publicat: (2022-08-01)

Peroxisomal chain-shortening of thromboxane B2: evidence for impaired degradation of thromboxane B2 in Zellweger syndrome
per: U Diczfalusy, et al.
Publicat: (1993-07-01)

Thromboxane Modulates Endothelial Permeability
per: J. M. Klausner, et al.
Publicat: (1994-01-01)

Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples
per: Giovanna Petrucci, et al.
Publicat: (2024-11-01)

Divergent roles of prostacyclin and PGE2 in human tendinopathy
per: Filip Bergqvist, et al.
Publicat: (2019-03-01)

Glycyrrhizin Suppresses Lung Adenocarcinoma Cell Growth Through Inhibition of Thromboxane Synthase
per: Run-Yue Huang, et al.
Publicat: (2014-02-01)

Aspirin intake in the morning is associated with suboptimal platelet inhibition, as measured by serum Thromboxane B2, during infarct-prone early-morning hours
per: Cati Racca, et al.
Publicat: (2019-10-01)

Prostacyclin Regulation of Allergic Inflammation
per: Kunj Patel, et al.
Publicat: (2022-11-01)

Effects Of Prostacyclın In Osteoclastıc Actıvatıon
per: Yalçın Işımer, et al.
Publicat: (1990-11-01)

Suppression of scarring in peripheral nerve implants by drug elution
per: FitzGerald, J
Publicat: (2016)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
per: Sarah Parish, et al.
Publicat: (2023-03-01)

Divergent roles of prostacyclin and PGE2 in human tendinopathy.
per: Bergqvist, F, et al.
Publicat: (2019)

Elevated neutrophil extracellular traps in systemic sclerosis-associated vasculopathy and suppression by a synthetic prostacyclin analog
per: Neda Kortam, et al.
Publicat: (2024-07-01)

Stability of thromboxane in blood samples
per: Helgadóttir H, et al.
Publicat: (2019-06-01)

Selective inhibition by antiflamrnin-2 of thromboxane B2 release from isolated and perfused guinea-pig lung
per: Lidia Sautebin, et al.
Publicat: (1992-01-01)

Physiological Significance of Thromboxane A2 Receptor Dimerization
per: Masako Sasaki, et al.
Publicat: (2006-01-01)

Aspirin resistance status as determined by urinary thromboxane B2 (TXB2) level in patients with ischemic heart disease and its relationship with Severity of coronary artery disease
per: Naghmeh Ziaie, et al.
Publicat: (2011-01-01)

Comment on ‘SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung’
per: Ethan S FitzGerald, et al.
Publicat: (2022-01-01)

Measurement of Thromboxane Biosynthesis in Health and Disease
per: Carlo Patrono, et al.
Publicat: (2019-10-01)

Inhibiting breast cancer by targeting the thromboxane A2 pathway
per: Haitao Li, et al.
Publicat: (2017-04-01)

Prostacyclin-analog therapy in sickle cell pulmonary hypertension
per: Nargues A. Weir, et al.
Publicat: (2017-05-01)

Administration of Slow-Release Synthetic Prostacyclin Agonist Promoted Angiogenesis and Skeletal Muscle Regeneration for Limb Ischemia
per: Takaya Nakagawa, et al.
Publicat: (2020-09-01)

Thromboxane A2 Up-Regulates Neutrophil Elastase Release in Syrian Hamsters With Trinitrobenzene Sulfonic Acid-Induced Colitis
per: Yasushi Hirota, et al.
Publicat: (2005-01-01)

Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma developmentResearch in context
per: Tianshun Zhang, et al.
Publicat: (2019-11-01)

Severe pulmonary hypertension–interstitial lung disease presenting as right ventricular failure: stabilisation with intravenous prostacyclin and maintenance with inhaled prostacyclin
per: Raj Parikh, et al.
Publicat: (2024-01-01)

Thromboxane biosynthesis and future events in diabetes: the ASCEND trial
per: Petrucci, G, et al.
Publicat: (2024)

Factors Associated with Aspirin Resistance in Hong Kong Chinese Patients with Stable Coronary Heart Disease Using the Multiplate<sup>®</sup> Analyzer and Serum Thromboxane B<sub>2</sub>
per: Weiwei Zeng, et al.
Publicat: (2022-10-01)

Urinary 11‐Dehydro‐Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
per: Wojciech Szczeklik, et al.
Publicat: (2016-08-01)